Sun08192018

Robins Global News & Noticias



  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • 2018 FIFA World Cup
    2018 FIFA World Cup
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

+ Larger Font | + Smaller Font

Consumer Daily Reports

Consumer News: FDA shames companies accused of blocking generic drug development

PhotoOn Thursday, the Food and Drug Administration (FDA) publicly called out companies charged with blocking the development of generic drugs. According to generic manufacturers, brand name manufacturers are responsible for countless hurdles that delay production and development of generic medication, and this list is designed to put an end to that.

“Today we’re making a public list of companies that have potentially been blocking access to the samples of their branded products,” said FDA Commissioner Scott Gottlieb. “We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and approval.”

To ensure that generic medications are safe for consumer use -- and identical to the brand name -- generic drug makers need brand name manufacturers to be on their team, as they need access to the brand name samples. The now-public list shows each complaint generic drug companies have made against the brand name companies.

Companies like Pfizer, GlaxoSmithKline, Novartis, and Valeant Pharmaceuticals -- just to name a few -- made the list of brand name companies that have been thwarting generic drug production. Additionally, Celegne topped the list with 13 complaints made against it to the FDA.

“No patients should be priced out of medicines they need to support their health,” Gottlieb said.

What this means for consumers

This move by the FDA comes after the White House released its plan to reduce drug prices for consumers. The plan, released last Friday, has four major goals: increasing competition, easing negotiation, creating incentives for lower prices, and lowering out-of-pocket spending on drugs.

The way the current system stands, drug companies have free reign to charge whatever they see fit for their products. With a new drug comes the ability to patent it; however, the FDA can also grant exclusivity to prevent competition in the market for certain periods of time. While drugmakers have various ways of doing this, their main tactic is to try to prevent competitors from creating copies.

“At times, certain ‘gaming tactics’ have been used to delay generic competition,” the FDA said in a statement. “One example of such gaming is when potential generic applicants are prevented from obtaining samples of certain brand products necessary to support approval of a generic drug. The inability of generic drug companies to purchase the samples they need slows down, or entirely impedes, the generic drug development process -- leading to delays in bringing affordable generic alternatives to patients in need.”

“This is a great day for for patients, since the administration’s list makes the definitive case why brand-name drug companies must stop blocking generic competition,” said Allen Goldberg, vice president of communications for the Association of Accessible Medicines.

There is currently legislation in the works that will aid in limiting what brand-name manufacturers can do to block generic competition. The CREATES Act has bipartisan support and will make it easier for generic manufacturers to sue for their right to provide consumers with cheaper copies of brand-name drugs. Despite support from both sides of the aisle, the bill is being held up amidst great opposition from drug companies.

“All the scheming and exploitation of our government’s rules means more profits for corporations at the expense of everyday Americans struggling to get the life-saving medicines they need,” said Tahir Amin, co-founder of Initiative for Medicines, Access & Knowledge.



Posted: 2018-05-18 11:44:34

Get Full News Story On Consumer Affairs


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Consumer News: FDA shames companies accused of blocking generic drug development | Consumer Daily Reports - Newscast

FDA names drugmakers accused of blocking cheaper generics

Mon, 21 May 2018 05:59:00 GMT

U.S. drug regulators are ... to ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects. Celgene is accused of using a secon...

FDA names drugmakers accused of blocking cheaper generics

Thu, 17 May 2018 11:56:00 GMT

TRENTON, N.J. — U.S. drug regulators ... ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects. Celgene is accused of usin...

FDA names drugmakers accused of blocking cheaper generics

Thu, 17 May 2018 11:33:00 GMT

TRENTON, N.J. (AP) — U.S. drug regulators ... ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects. Celgene is accused of ...

FDA names drugmakers accused of blocking cheaper generics

Thu, 17 May 2018 10:23:00 GMT

The Food and Drug ... generic versions on the market since its three drugs on the list carries serious risks including birth defects. Why does HHS OIG’s budget keep rising as its output keeps falling? ...

FDA names, shames anticompetitive drug companies

Thu, 17 May 2018 09:24:00 GMT

... Gottlieb Thursday made public a list of 41 branded drug companies that generic manufacturers have accused of blocking access to drug samples in order to thwart development of competitive generic d...

Related Bing Web Search

Stockpiling Biologics Under Hatch-Waxman Protection - Law360

(Mon, 23 Oct 2017 11:42:00 GMT)

The district court denied Hospira’s motion for summary judgment. The court held that there were genuine disputes of material fact as to whether Hospira’s manufacturing activities were “solely for uses reasonably related to the development and submission of information” to the U.S. Food & Drug Administration.

Wednesday, November 1, 2017 | Kaiser Health News

(Thu, 26 Jul 2018 03:01:00 GMT)

Kaiser Health News Original Stories 3 Timeline: Despite GOP’s Failure To Repeal Obamacare, The ACA Has Changed; Funding For ACA Sign-Up Campaigns Varies Widely From State To State

Escitalopram - Wikipedia

(Wed, 15 Aug 2018 08:14:00 GMT)

Escitalopram, sold under the brand names Cipralex and Lexapro among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Escitalopram is mainly used to treat major depressive disorder or generalized anxiety disorder.

Antipsychotic - Wikipedia

(Sun, 12 Aug 2018 07:28:00 GMT)

Antipsychotic drug treatment is a key component of schizophrenia treatment algorithms recommended by the National Institute of Health and Care Excellence (NICE), the American Psychiatric Association, and the British Society for Psychopharmacology.

Emergency Pain Relief While On Suboxone | Suboxone Talk ...

(Tue, 14 Aug 2018 16:58:00 GMT)

The manufacturer, Reckitt Benckiser, was trying to get rid of generic competition– so they came out with the film, then filed a citizen’s petition with the FDA claiming that tablets were unsafe.

DPIC | Death Penalty Information Center

(Tue, 19 Sep 2017 01:52:00 GMT)

Less than a month after a Nevada court halted the execution of Scott Dozier in response to a lawsuit filed by generic-drug manufacturer Alvogen, another drug company has sued Nebraska, seeking to block the use of its medicines in an upcoming execution.

Part II. Core Issues for All Schools to Consider

(Tue, 07 Aug 2018 16:45:00 GMT)

First Amendment in Schools. by Charles C. Haynes, Sam Chaltain, John E. Ferguson Jr., David L. Hudson Jr. and Oliver Thomas. Table of Contents. Chapter 1.

Crime Scene Training: Latent Fingerprints

(Wed, 15 Aug 2018 13:58:00 GMT)

Crime Scene Training A blog to teach the fundamentals of Crime Scene Investigation, and to encourage input, feedback and involvement from site visitors.

Fetch.News

(Thu, 26 Jul 2018 20:41:00 GMT)

The world of independent media, all in one place.

Headache NewsBlog | The New York Headache Center is a ...

(Thu, 09 Aug 2018 16:49:00 GMT)

Caffeine can be considered a drug since it is available in a pure form in tablets and injections. It is also included in medications, such as Excedrin, Fioricet, and Fiorinal.

Related News Story Videos From Youtube

Trump vows to lower prescription drug costs


Related Videos On: Trump vows to lower prescription drug costs


Obama Blocks Poor Nations' Access to Affordable Drugs


Related Videos On: Obama Blocks Poor Nations' Access to Affordable Drugs


Boomerang Trick Shots | Dude Perfect


Related Videos On: Boomerang Trick Shots | Dude Perfect


Fredericton police ID 2 officers killed in shooting, suspect in hospital


Related Videos On: Fredericton police ID 2 officers killed in shooting, suspect in hospital


State of the Union Address 2018 and Democratic response: Coverage and live stream from CBSN


Related Videos On: State of the Union Address 2018 and Democratic response: Coverage and live stream from CBSN






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2018 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.